Last 23 quarters of trend data · Healthcare · Medical - Care Facilities
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
LifeStance Health Group, Inc.'s quarterly P/E stands at 44.2x, down 95.2% year-over-year — suggesting improving earnings relative to price. EV/EBITDA has compressed 63.1% YoY to 17.6x, reflecting multiple compression or accelerating EBITDA.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 449.00 | 44.24 | 69.84 | 491.07 | — | 925.00 | — | — | — | — | — | — | — |
| — | -95.2% | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 2.45 | 1.56 | 1.80 | 1.47 | 1.44 | 1.95 | 2.17 | 2.12 | 1.49 | 1.93 | 2.64 | 2.43 | 3.19 |
| — | -20.2% | -16.9% | -30.6% | -3.4% | +1.1% | -18.0% | -12.9% | -53.3% | -27.2% | +30.5% | -10.5% | +36.1% | |
| P/B Ratio | 2.31 | 1.70 | 1.81 | 1.43 | 1.35 | 1.79 | 1.95 | 1.84 | 1.30 | 1.62 | 2.08 | 1.76 | 2.22 |
| — | -4.6% | -7.2% | -22.3% | +3.7% | +9.9% | -6.0% | +4.9% | -41.3% | -8.8% | +69.7% | +13.8% | +72.7% | |
| P/FCF | 31.65 | 28.16 | 8.32 | 31.46 | 8.79 | — | 12.59 | 37.50 | 11.96 | — | 137.77 | — | — |
| — | — | -33.9% | -16.1% | -26.5% | — | -90.9% | — | — | — | +657.6% | — | — | |
| EV / EBITDA | 42.61 | 17.64 | 21.16 | 28.72 | 51.46 | 47.86 | 50.09 | 50.04 | 214.22 | 119.92 | — | — | — |
| — | -63.1% | -57.7% | -42.6% | -76.0% | -60.1% | — | — | — | — | — | — | — | |
| EV / EBIT | 133.36 | 28.14 | 37.33 | 81.53 | — | 458.60 | 1515.08 | 24476.36 | — | — | — | — | — |
| — | -93.9% | -97.5% | -99.7% | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
LifeStance Health Group, Inc.'s operating margin was 5.5% in Q1 2026, up 0.7 pp QoQ and up 5.1 pp YoY. This marks the 4th consecutive quarter of margin expansion, signaling a sustained improvement in operating efficiency. The trailing four-quarter average of 2.9% lags the current quarter, suggesting the recent improvement is above-trend. Gross margin contracted 7.8% YoY, suggesting cost inflation or competitive pricing pressure.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 28.5% | 30.4% | 29.5% | 32.0% | 27.3% | 33.0% | 33.6% | 32.1% | 31.3% | 31.5% | 29.7% | 29.0% | 28.1% |
| — | -7.8% | -12.2% | -0.2% | -12.7% | +4.6% | +13.2% | +10.8% | +11.4% | +14.4% | +8.6% | +4.6% | -1.6% | |
| Operating Margin | 1.8% | 5.5% | 4.8% | 2.0% | -0.9% | 0.5% | 0.3% | 0.0% | -5.1% | -5.6% | -11.5% | -28.3% | -18.7% |
| — | +1051.0% | +1383.4% | +13478.7% | +83.3% | +108.6% | +102.8% | +100.1% | +72.6% | +58.6% | +42.7% | -58.4% | +35.4% | |
| Net Margin | 0.7% | 3.5% | 3.1% | 0.3% | -1.1% | 0.2% | -2.2% | -1.9% | -7.5% | -7.0% | -16.0% | -23.4% | -17.5% |
| — | +1558.1% | +239.7% | +115.5% | +85.3% | +103.0% | +86.4% | +91.9% | +57.5% | +48.2% | +21.2% | -34.6% | +46.6% |
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 0.7% | 0.9% | 0.8% | 0.1% | -0.3% | 0.0% | -0.5% | -0.4% | -1.6% | -1.5% | -3.1% | -4.2% | -3.0% |
| — | +1846.7% | +257.0% | +117.5% | +84.1% | +103.3% | +84.2% | +90.0% | +46.3% | +34.8% | -1.9% | -68.9% | +32.2% | |
| ROA | 0.4% | 0.7% | 0.5% | 0.1% | -0.2% | 0.0% | -0.3% | -0.3% | -1.1% | -1.0% | -2.1% | -2.8% | -2.1% |
| — | +1849.1% | +259.3% | +117.8% | +83.8% | +103.4% | +84.0% | +90.1% | +47.6% | +36.7% | +6.6% | -47.8% | +40.0% | |
| ROIC | 1.2% | 1.1% | 0.9% | 0.3% | -0.1% | 0.1% | 0.0% | 0.0% | -0.6% | -0.7% | -1.3% | -2.9% | -1.9% |
| — | +1592.9% | +1843.3% | +16510.5% | +80.6% | +110.0% | +103.4% | +100.1% | +66.2% | +50.1% | +33.9% | -65.3% | +32.1% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
LifeStance Health Group, Inc.'s Debt/EBITDA ratio is 5.5x, down from 6.1x last quarter — elevated, raising questions about debt serviceability.
| Metric | TTM | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.13 | 0.13 | 0.13 | 0.32 | 0.32 | 0.32 | 0.34 | 0.34 | 0.35 | 0.35 | 0.36 | 0.33 | 0.33 |
| — | -59.1% | -62.0% | -6.3% | -7.5% | -8.3% | -6.2% | +1.4% | +4.4% | +12.3% | +13.4% | +141.3% | +150.7% | |
| Debt / EBITDA | 2.41 | 5.50 | 6.09 | 22.59 | 42.89 | 30.80 | 30.84 | 32.10 | 187.46 | 87.32 | — | — | — |
| — | -82.1% | -80.3% | -29.6% | -77.1% | -64.7% | — | — | — | — | — | — | — | |
| Current Ratio | 1.65 | 1.48 | 1.65 | 1.58 | 1.48 | 1.47 | 1.37 | 1.32 | 1.22 | 1.18 | 1.11 | 1.10 | 1.32 |
| — | +1.1% | +21.0% | +19.5% | +21.4% | +24.8% | +22.7% | +20.3% | -7.2% | +0.3% | -16.0% | -51.2% | -39.9% | |
| Quick Ratio | 1.65 | 1.48 | 1.65 | 1.58 | 1.48 | 1.47 | 1.37 | 1.32 | 1.22 | 1.18 | 1.11 | 1.10 | 1.32 |
| — | +1.1% | +21.0% | +19.5% | +21.4% | +24.8% | +22.7% | +20.3% | -7.2% | +0.3% | -16.0% | -51.2% | -39.9% | |
| Interest Coverage | 2.06 | 12.48 | 6.29 | 2.62 | -1.05 | 0.52 | 0.06 | 0.01 | -2.88 | -2.51 | -5.93 | -13.24 | -9.16 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 23 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying LFST stock.
LifeStance Health Group, Inc.'s current P/E is 449.0x. The average P/E over the last 3 quarters is 201.7x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
LifeStance Health Group, Inc.'s current operating margin is 1.8%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking LifeStance Health Group, Inc.'s business trajectory between earnings reports.